Purchase this article with an account.
Eduardo Martinez Sanchez, Valeria Oliva, Arturo Gomez Bastar, Arturo Lichtinger, Aida Jimenez-Corona, Enrique O Graue-Hernandez, Arturo J Ramirez-Miranda, Alejandro Navas; Three years follow-up of central flow toric implantable collamer lens implantation. Invest. Ophthalmol. Vis. Sci. 2018;59(9):5752.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To evaluate outcomes of toric phakic implantable collamer lens (ICL) V4c for moderate to high myopic astigmatism in a three years follow-up in a Mexican population sample.
Retrospective study included 99 eyes of 53 patients who underwent toric ICL V4c. We assessed visual outcomes, refraction, intraocular pressure (IOP), vaulting and endothelial cell density (ECD).
Mean preoperative UDVA was 1.5 (logMAR), CDVA was 0.18 (logMAR), mean spherical equivalent (SE) was -11.42 diopters (D). After 3-year follow-up, average UDVA was 0.18, SE was -0.74 D, these changes were statistically significant. CDVA, IOP and vaulting did not show significant differences. Paired T-test was used.
Toric ICL V4c implantation improved UDVA from 1.5 logMar to 0.20 logMar after central flow ICL implantation. Toric ICL V4c log term follow-up showed that patients with moderate to high myopic astigmatism that had been treated with this lens have experienced good results.
This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.
This PDF is available to Subscribers Only